Shujiro Okuda
Overview
Explore the profile of Shujiro Okuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
12384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, et al.
Breast Cancer
. 2025 Jan;
32(2):404-415.
PMID: 39808396
Purpose: The aim of this study was to examine the clinical utility of tumor-infiltrating lymphocytes (TILs) evaluated by "average" and "hot-spot" methods in breast cancer patients. Methods: We examined 367...
2.
Takahashi Y, Karlsson N, Okuda S, Aoki-Kinoshita K
Anal Bioanal Chem
. 2024 Nov;
417(5):1015-1023.
PMID: 39611991
In glycomics, two data repositories, GlycoPOST and UniCarb-DR, have been developed to accumulate experimental data generated by glycomics and glycoproteomics mass spectrometry experiments. In order to enhance the interrelation between...
3.
Okuda S, Yoshizawa A, Kobayashi D, Takahashi Y, Watanabe Y, Moriya Y, et al.
Nucleic Acids Res
. 2024 Nov;
53(D1):D462-D467.
PMID: 39526391
jPOST (https://jpostdb.org/) comprises jPOSTrepo (https://repository.jpostdb.org/) (over 2000 projects), a repository for proteome mass spectrometry data, the reanalysis of raw proteome data based on a standardised protocol using UniScore, and jPOSTdb...
4.
Katsumi T, Hayashi R, Takei S, Ansai O, Takatsuka S, Takenouchi T, et al.
J Dermatol
. 2024 Nov;
51(11):1461-1469.
PMID: 39487562
Schwannomas consist of both high-cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei...
5.
Insights into predicting small molecule retention times in liquid chromatography using deep learning
Liu Y, Yoshizawa A, Ling Y, Okuda S
J Cheminform
. 2024 Oct;
16(1):113.
PMID: 39375739
In untargeted metabolomics, structures of small molecules are annotated using liquid chromatography-mass spectrometry by leveraging information from the molecular retention time (RT) in the chromatogram and m/z (formerly called ''mass-to-charge...
6.
Shiroma H, Darzi Y, Terajima E, Nakagawa Z, Tsuchikura H, Tsukuda N, et al.
Brief Bioinform
. 2024 Sep;
25(5).
PMID: 39222063
The human gut microbiota produces diverse, extensive metabolites that have the potential to affect host physiology. Despite significant efforts to identify metabolic pathways for producing these microbial metabolites, a comprehensive...
7.
Okuda A, Sugai K, Okuda S
Biochem Biophys Res Commun
. 2024 Aug;
733:150586.
PMID: 39197200
The modified cell-penetrating peptide Pas2r12 can deliver antibodies (IgG, 150 kDa) and enhanced green fluorescent protein (EGFP, 27 kDa) into the cytosol through caveolae-dependent endocytosis. In this study, we determined...
8.
Hsiao Y, Yoshida Y, Okuda S, Abe M, Mizuno S, Takahashi S, et al.
EMBO J
. 2024 Aug;
43(21):4846-4869.
PMID: 39160276
Metabolic dysfunction-associated steatohepatitis (MASH, previously termed non-alcoholic steatohepatitis (NASH)), is a major complication of obesity that promotes fatty liver disease. MASH is characterized by progressive tissue fibrosis and sterile liver...
9.
Ichikawa H, Aizawa M, Kano Y, Hanyu T, Muneoka Y, Hiroi S, et al.
Gastric Cancer
. 2024 Aug;
27(6):1273-1286.
PMID: 39110344
Background: Homologous recombination deficiency (HRD) is one of the crucial hallmarks of cancer. It is associated with a favorable response to platinum-based chemotherapy. We explored the distinctive clinicopathological features of...
10.
Ichikawa H, Usui K, Aizawa M, Shimada Y, Muneoka Y, Kano Y, et al.
BMC Cancer
. 2024 Jun;
24(1):719.
PMID: 38862927
Background: Evaluation of human epidermal growth factor receptor 2 (HER2) overexpression caused by erb-b2 receptor tyrosine kinase 2 (ERBB2) amplification (AMP) by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)...